Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19: a protocol for a pragmatic, parallel randomised controlled trial (Medicine, 2021)

(untitled) - Manfrin, A; Jackson, C; Campisi, R; Oteri, A; Copani, A; Desideri, E; Tsiachristas, A; Candio, P; Di Tomaso, G; Vitale, M; Crimi, N